Results 61 to 70 of about 30,968 (78)

Targeting KRAS in pancreatic cancer: new drugs on the horizon

Cancer and Metastasis Reviews, 2021
Misako Nagasaka, Md Hafiz Uddin, Bassel El-Rayes   +2 more
exaly  

Mutant KRAS Enhances Tumor Cell Fitness by Upregulating Stress Granules

Cell, 2016
Elda Grabocka, Dafna Bar-Sagi
exaly  

KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS

Cell, 2018
Marzia Capelletti, Haiyun Wang, Sudershan Gondi   +2 more
exaly  

Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor

Cell, 2018
Liansheng Li
exaly  

KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer

Cancer Cell, 2019
Michael Overman, Jianhua Zhang, Di Zhao   +2 more
exaly  

Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase

Cancer Cell, 2018
Tina Cowan, Anna Scott, Davide Ruggero   +2 more
exaly  

Targeting the untargetable KRAS in cancer therapy

Acta Pharmaceutica Sinica B, 2019

exaly  

Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer

Annals of Oncology, 2016
Giuseppe Giaccone, K L Reckamp, L A Doyle   +2 more
exaly  

Differential Effector Engagement by Oncogenic KRAS

Cell Reports, 2018
Ji Luo, Ellen Murchie, Arnaud Amzallag   +2 more
exaly  

KRAS Alleles: The Devil Is in the Detail

Trends in Cancer, 2017
Kevin Haigis
exaly